BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9094450)

  • 21. DNA vaccines: a rational design against parasitic diseases.
    Carvalho JA; Rodgers J; Atouguia J; Prazeres DM; Monteiro GA
    Expert Rev Vaccines; 2010 Feb; 9(2):175-91. PubMed ID: 20109028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice.
    Chen J; Liu Q; Chen Q; Xiong C; Yao Y; Wang H; Wang H; Chen Z
    Arch Virol; 2014 Apr; 159(4):689-700. PubMed ID: 24132721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cationic influenza virosomes as an adjuvanted delivery system for CTL induction by DNA vaccination.
    Jamali A; Holtrop M; de Haan A; Hashemi H; Shenagari M; Memarnejadian A; Roohvand F; Sabahi F; Kheiri MT; Huckriede A
    Immunol Lett; 2012; 148(1):77-82. PubMed ID: 22981929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effectiveness and limitations of immune memory: understanding protective immune responses.
    Campos M; Godson DL
    Int J Parasitol; 2003 May; 33(5-6):655-61. PubMed ID: 12782062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein.
    Fonseca DP; Benaissa-Trouw B; van Engelen M; Kraaijeveld CA; Snippe H; Verheul AF
    Infect Immun; 2001 Aug; 69(8):4839-45. PubMed ID: 11447158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA vaccines for biodefence.
    Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene.
    Bot A; Antohi S; Bot S; Garcia-Sastre A; Bona C
    Int Immunol; 1997 Nov; 9(11):1641-50. PubMed ID: 9418125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effector and memory CTL differentiation.
    Williams MA; Bevan MJ
    Annu Rev Immunol; 2007; 25():171-92. PubMed ID: 17129182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection.
    Bragstad K; Vinner L; Hansen MS; Nielsen J; Fomsgaard A
    Vaccine; 2013 Apr; 31(18):2281-8. PubMed ID: 23499598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant.
    Karlsson I; Borggren M; Nielsen J; Christensen D; Williams J; Fomsgaard A
    Hum Vaccin Immunother; 2017 Aug; 13(8):1823-1830. PubMed ID: 28613978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective immunity induced by rotavirus DNA vaccines.
    Chen SC; Fynan EF; Robinson HL; Lu S; Greenberg HB; Santoro JC; Herrmann JE
    Vaccine; 1997 Jun; 15(8):899-902. PubMed ID: 9234543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance?
    Niezold T; Storcksdieck Genannt Bonsmann M; Maaske A; Temchura V; Heinecke V; Hannaman D; Buer J; Ehrhardt C; Hansen W; Überla K; Tenbusch M
    Immunology; 2015 Aug; 145(4):519-33. PubMed ID: 25819746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE; Zhang J; Whitton JL
    Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of protection against influenza A virus by DNA vaccine encoding the hemagglutinin gene.
    Operschall E; Pavlovic J; Nawrath M; Mölling K
    Intervirology; 2000; 43(4-6):322-30. PubMed ID: 11251388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza.
    Baranowska M; Hauge AG; Hoornaert C; Bogen B; Grødeland G
    Vaccine; 2015 Dec; 33(49):6988-96. PubMed ID: 26387432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA vaccination strategies against infectious diseases.
    Watts AM; Kennedy RC
    Int J Parasitol; 1999 Aug; 29(8):1149-63. PubMed ID: 10576567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technical and regulatory hurdles for DNA vaccines.
    Donnelly J; Berry K; Ulmer JB
    Int J Parasitol; 2003 May; 33(5-6):457-67. PubMed ID: 12782047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.